CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $32.26M, above the global median of $18.73M
- PositionGross margin is 16.8%, lower than 95% of its Diagnostics & Research peers (median 56.7%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.97BCNY592.41M · vs all stocks (USD)
Revenue (TTM)
836.23MCNY124.87M · vs all stocks (USD)
Profit Margin
-23.80%vs Diagnostics & Research peers
Beta
0.3240xvs all stocks
52-Week Change
-35.85%vs all stocks
Market Capitalization
3.97BCNY592.41M · vs all stocks (USD)
Enterprise Value
3.68BCNY549.21M · vs all stocks (USD)
Forward P/E
17.39xvs Diagnostics & Research peers
Price to Sales (TTM)
4.37xvs Diagnostics & Research peers
Price to Book (MRQ)
3.20xvs Diagnostics & Research peers
Enterprise to Revenue
4.40xvs Diagnostics & Research peers
Enterprise to EBITDA
-56.68xvs Diagnostics & Research peers
Gross Margin
16.80%vs Diagnostics & Research peers
Profit Margin
-23.80%vs Diagnostics & Research peers
Operating Margin
-16.26%vs Diagnostics & Research peers
Return on Assets (TTM)
-2.92%vs Diagnostics & Research peers
Return on Equity (TTM)
-21.49%vs Diagnostics & Research peers
Revenue (TTM)
836.23MCNY124.87M · vs all stocks (USD)
Revenue per Share (TTM)
3.97CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-42.10%vs Diagnostics & Research peers
Gross Profit (TTM)
171.84MCNY25.66M · vs all stocks (USD)
EBITDA (TTM)
-64.89MCNY-9.69M · vs all stocks (USD)
Net Income (TTM)
-199.00MCNY-29.72M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-43.99%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
6.63MCNY990.57K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
216.01MCNY32.26M · vs all stocks (USD)
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
-40.20MCNYFY2025 · Dec 31, 2025Revenue
1.08BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
836.63MCNYFY2025 · Dec 31, 2025Gross Profit
240.33MCNYFY2025 · Dec 31, 2025Operating Income
-58.04MCNY-8.67M · vs all stocks (USD)
Pre-tax Income
-152.36MCNYFY2025 · Dec 31, 2025Income Tax Expense
49.08MCNYFY2025 · Dec 31, 2025Net Income
-201.44MCNYFY2025 · Dec 31, 2025EBIT
-118.84MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-10.85MCNYFY2025 · Dec 31, 2025Research & Development
41.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
100.53MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.56MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
33.53MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.04CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.04CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
199.31MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
199.31MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-201.44MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.84MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-51.57MCNYFY2025 · Dec 31, 2025Free Cash Flow
-57.16MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
122.10MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-201.44MCNYFY2025 · Dec 31, 2025Other Non-cash Items
40.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-32.03MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
141.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-5.59MCNYFY2025 · Dec 31, 2025Net Acquisitions
40.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-33.69MCNYFY2025 · Dec 31, 2025Sale of Investments
4.01MCNYFY2025 · Dec 31, 2025Other Investing Activity
25.07MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
30.21MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
317.83MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-326.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.56MCNYFY2025 · Dec 31, 2025Other Financing Charges
-39.73MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-67.15MCNYFY2025 · Dec 31, 2025Shares Outstanding
225.79MSharesUpdated Sep 22, 2026Float Shares
189.76MSharesUpdated Sep 22, 2026% Held by Insiders
17.16%vs all stocks
% Held by Institutions
4.00%vs all stocks
Total Cash (MRQ)
96.22MCNY14.37M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4340CNYUpdated Sep 22, 2026Total Debt (MRQ)
253.51MCNY37.86M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2470xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.90xvs Diagnostics & Research peers
Book Value per Share (MRQ)
5.06CNYUpdated Sep 22, 2026Total Assets
1.80BCNY269.16M · vs all stocks (USD)
Total Current Assets
1.24BCNYFY2025 · Dec 31, 2025Total Liabilities
897.96MCNYFY2025 · Dec 31, 2025Total Non-current Assets
564.08MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
25.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
872.77MCNYFY2025 · Dec 31, 2025Cash
121.92MCNYFY2025 · Dec 31, 2025Cash Equivalents
9.01MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
130.94MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.35MCNYFY2025 · Dec 31, 2025Accounts Receivable
734.08MCNYFY2025 · Dec 31, 2025Inventory
223.38MCNYFY2025 · Dec 31, 2025Accounts Payable
260.82MCNYFY2025 · Dec 31, 2025Short-term Debt
436.66MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.88MCNYFY2025 · Dec 31, 2025Long-term Debt
19.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
210.19MCNYFY2025 · Dec 31, 2025Retained Earnings
-162.27MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
904.49MCNY135.07M · vs all stocks (USD)
Treasury Stock
24.03MCNYFY2025 · Dec 31, 202552-Week Low
12.92CNYUpdated Sep 22, 202652-Week High
31.86CNYUpdated Sep 22, 202652-Week Change
-35.85%vs all stocks
Beta
0.3240xvs all stocks
50-Day MA
16.28CNYUpdated Sep 22, 2026200-Day MA
19.79CNYUpdated Sep 22, 2026Avg 10-Day Volume
8.93MSharesUpdated Sep 22, 2026Avg 30-Day Volume
15.70MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.9700CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 16.8%, lower than 95% of its Diagnostics & Research peers (median 56.7%)Significant
Gross margin: 0.17Industry median: 0.57Industry P5: 0.22Peers compared: 30.00
Return on equity is -21.5%, lower than 95% of its Diagnostics & Research peers (median 1.2%)Significant
Return on equity: -0.21Industry median: 0.01Industry P5: -0.21Peers compared: 30.00
Financial Health
Altman Z-Score 3.15: safe zoneNotable
Altman Z-Score: 3.15
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Levered free cash flow is $32.26M, above the global median of $18.73MNotable
Levered free cash flow (USD): 32,256,699.232Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Ningbo Solartron Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Healthcare Co Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
KMW Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fawer Automotive Parts Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Mustang Battery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Nanjing Huamai Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wagners Holding Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ningbo Jianan Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanxi Huhua Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Union Optech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow